Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 1/20 | 0.70 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | LTA4H | P09960 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.47 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.47 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11311102 | 0.91 | NQO1 (0.64) | NQO1TSHRTDP1LTA4HNPC1 | |
| SCHEMBL11122915 | 0.91 | NQO1 (0.64) | NQO1TSHRTDP1LTA4HNPC1 | |
| SCHEMBL10951255 | 0.85 | NQO1 (0.70) | NQO1TSHRTDP1LTA4HNPC1 | |
| 1,4-Diethoxybenzene SCHEMBL28186701 | 0.84 | NQO1 (1.00) | NQO1TSHRTDP1LTA4HNPC1 | |
| 1,4-Diethoxybenzene SCHEMBL124015 | 0.84 | NQO1 (1.00) | NQO1TSHRTDP1LTA4HNPC1 | |
| SCHEMBL24196870 | 0.83 | NQO1 (0.67) | NQO1TSHRTDP1LTA4HNPC1 | |
| SCHEMBL11560871 | 0.83 | NQO1 (0.67) | NQO1TSHRTDP1LTA4HNPC1 | |
| SCHEMBL6972139 | 0.83 | NQO1 (0.67) | NQO1TSHRTDP1LTA4HNPC1 | |
| SCHEMBL945686 | 0.81 | LTA4H (0.55) | TSHRLTA4HCA12CA1CA2 | |
| SCHEMBL11257549 | 0.81 | NQO1 (0.64) | NQO1TSHRTDP1LTA4HNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018131-A1 | MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF | FORESEE PHARMACEUTICALS USA, INC. | 2024-01-18 | — | — | US | disclosed |
| US-11739080-B2 | Matrix metalloproteinase (MMP) inhibitors and methods of use thereof | FORESEE PHARMACEUTICALS USA, INC. (US) | 2023-08-29 | — | — | US | disclosed |
| CN-108440375-A | Using disulfide as the catalysis oxidation synthetic method of the 3- sulfydryl indole class compounds of sulphur source | 浙江工业大学 | 2018-08-24 | — | — | CN | disclosed |
| US-8987516-B2 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES, LTD. (JP) | 2015-03-24 | — | — | US | disclosed |
| EP-2468722-B1 | Process for producing arylsulfur halotetrafluorides | UBE INDUSTRIES (JP) | 2014-10-01 | — | — | EP | disclosed |
| EP-2468721-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2014-02-26 | — | — | EP | disclosed |
| US-20130330607-A1 | ELECTROLYTIC SOLUTION AND LITHIUM-ION SECONDARY BATTERY | KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) | 2013-12-12 | — | — | US | disclosed |
| EP-2468720-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2013-11-27 | — | — | EP | disclosed |
| EP-2468719-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2013-10-16 | — | — | EP | disclosed |
| EP-2137144-B1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | UBE INDUSTRIES (JP) | 2013-07-31 | — | — | EP | disclosed |
| EP-0785208-B1 | Phosphonate nucleotide compounds | MITSUBISHI CHEM CORP (JP) | 2001-03-21 | — | — | EP | disclosed |
| US-5840716-A | ANTIVIRAL AGENTS | MITSUBISHI CHEMICAL CORPORATION (JP) | 1998-11-24 | — | — | US | disclosed |
| EP-0785208-A1 | Phosphonate nucleotide compounds | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-07-23 | — | — | EP | disclosed |
| US-5194539-A | Of ethylenically unsaturated monomers where the aqueous dispersion is free from odor causing xanthogen disulfide | RHONE-POULENC CHIMIE (FR) | 1993-03-16 | — | — | US | disclosed |
| US-4727178-A | Process for preparing phosphorodichloridothiolate | STAUFFER CHEMICAL CO. (US) | 1988-02-23 | — | — | US | disclosed |
| EP-0048710-A4 | PROCESS FOR PRODUCING HYDROGEN FROM WATER USING LIGHT ENERGY AND AQUEOUS COMPOSITIONS. | HERBST RALPH L JR | 1982-06-18 | — | — | EP | disclosed |
| EP-0048710-A1 | PROCESS FOR PRODUCING HYDROGEN FROM WATER USING LIGHT ENERGY AND AQUEOUS COMPOSITIONS | HERBST, Ralph L., Jr. (US) | 1982-04-07 | — | — | EP | disclosed |
| US-4303765-A | PEPTIZATION WITH AROMATIC POLYSULFIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-12-01 | — | — | US | disclosed |
| WO-1981002851-A1 | PROCESS FOR PRODUCING HYDROGEN FROM WATER USING LIGHT ENERGY AND AQUEOUS COMPOSITIONS | HERBST R | 1981-10-15 | — | — | WO | disclosed |
| US-4056581-A | Process for the preparation of phosphorodichloridothiolates | ROHM AND HAAS COMPANY (US) | 1977-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018131-A1 | MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF | MMP12, MMP1, MMP11 | NQO1 760/4885TSHR 4265/4885TDP1 2386/4885 |
| US-11739080-B2 | Matrix metalloproteinase (MMP) inhibitors and methods of use thereof | MMP12, MMP1, MMP11 | NQO1 760/4885TSHR 4265/4885TDP1 2386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.